ARTICLE | Company News
CAT and Wyeth-Ayerst in Alzheimer's deal
September 14, 2000 7:00 AM UTC
Cambridge Antibody Technology (LSE:CAT) granted Wyeth-Ayerst, a division of American Home Products (AHP), an exclusive license to develop antibody therapeutics specific for the amyloid beta peptide as...